The brain's rewarding system & addiction

Journal of Psychosocial Nursing and Mental Health Services

Volumn 42, Issue 6, 2004, Pages 14-18

  Bailey, Katharine P ^a  

^a Clinical Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ALCOHOLISM; ATTITUDE TO HEALTH; BRAIN; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MOTIVATION; NURSING; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; UNITED STATES; WITHDRAWAL SYNDROME;

ALCOHOL DRINKING; ALCOHOLISM; ATTITUDE TO HEALTH; BEHAVIOR, ADDICTIVE; BRAIN; FEMALE; HUMANS; MALE; MOTIVATION; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES;

EID: 3543059931     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20040601-08     Document Type: Review

References (12)

1. Childress, A.R., Mozley, P.D., McElgin, W., Fitzgerald, J., Reivich, M., & O'Brien, C.P. (1999). Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry, 11, 995-1006.
2. rd ed., pp. 639-690). New York: Churchill Livingston.
3. Harwood, H. (2000). Updating estimates of the economic costs of alcohol abuse in the United States: Estimates, update methods, and data (NIH Publication No. 98-4327). Rockville, MD: National Institutes of Health.
4. Kalivas, P.W., Sorg, B.A., & Hooks, M.S. (1993). The pharmacology and neural circuitry of sensitization to psychostimulants. Behavioral Pharmacology, 4, 315-334.
5. Kopnisky, K.L., & Hyman, S.E. (2002). Molecular and cellular biology of addiction. In K.L. Kavis, D. Charney, J.T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 1367-1379). Philadelphia: Lippincott Williams and Wilkins.
6. Le Moal, M. (1995). Mesocorticolimbic dopaminergic neurons functional and regulatory roles. In F.E. Bloom & D.J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 283-294). New York: Raven Press, Ltd.
7. McGinnis, J.M., & Foege, W.H. (1999). Mortality and morbidity attributable to use of addictive substances in the United States. Proceedings of the Association of American Physicians, 111, 109-118.
8. Nestler, E.J., & Aghajanian, G.K. (1997). Molecular and cellular basis of addiction. Science, 278, 58-63.
9. Nutt, D.J. (1996). Addiction: Brain mechanisms and their treatment implications. Lancet, 347, 31-36.
10. Shippenberg, T.S., & Koob, G.F. (2002). Recent advances in animal models of drug addiction In K.L. Kavis, D. Charney, J.T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 1381-1397). Philadelphia: Lippincott Williams and Wilkins.
11. Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National findings (NHSDA Series H-22, DHHS Publication No. SMA 03-3836). Rockville, MD: Author.
12. Young, A.M., & Goudie, A.J. (1995). Adaptive processes regulating tolerance to behavioral effects of drugs. In F.E. Bloom & D.J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 733-742). New York: Raven Press, Ltd.